Loading...
argenx SE
ARGNF•PNK
Healthcare
Biotechnology
$547.60
$0.00(0.00%)
argenx SE (ARGNF) Financial Performance & Statements
Review argenx SE’s income statement, balance sheet, and cash flow reports with annual and quarterly breakdowns.
Revenue Growth
77.27%
↑ 77.27%
Operating Income Growth
95.08%
↑ 95.08%
Net Income Growth
372.54%
↑ 372.54%
Operating Cash Flow Growth
80.31%
↑ 80.31%
Operating Margin
-1.24%
↓ 1.24%
Gross Margin
46.33%
↑ 46.33%
Net Profit Margin
37.53%
↑ 37.53%
ROE
16.50%
↑ 16.50%
ROIC
-0.48%
↓ 0.48%
argenx SE (ARGNF) Financial Statements
Explore quarterly and annual reports for argenx SE stock.
| Metric | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 |
|---|---|---|---|---|
| Revenue | $1.30B | $573.24M | $841.96M | $401.001M |
| Cost of Revenue | $641.82M | $59.07M | $509.52M | $43.18M |
| Gross Profit | $661.43M | $514.16M | $332.44M | $357.82M |
| Gross Profit Ratio | $0.51 | $0.90 | $0.39 | $0.89 |
| R&D Expenses | $514.67M | $235.94M | $414.01M | $224.97M |
| SG&A Expenses | $544.08M | $277.70M | $459.00M | $236.00M |
| Operating Expenses | $548.27M | $499.98M | $462.09M | $449.45M |
| Total Costs & Expenses | $1.19B | $559.05M | $971.61M | $492.63M |
| Interest Income | $20.33M | $40.59M | $72.006M | $38.90M |
| Interest Expense | $704000.00 | $676000.00 | $365254.00 | $512000.00 |
| Depreciation & Amortization | $8.60M | $74.51M | $8.05M | $24.05M |
| EBITDA | $125.94M | $88.70M | -$118.50M | -$54.53M |
| EBITDA Ratio | $0.10 | $0.15 | -$0.14 | -$0.14 |
| Operating Income | $103.04M | $14.19M | -$129.65M | -$93.42M |
| Operating Income Ratio | $0.08 | $0.02 | -$0.15 | -$0.23 |
| Other Income/Expenses (Net) | -$16.53M | $73.84M | $46.24M | $19.07M |
| Income Before Tax | $86.51M | $88.02M | -$83.41M | -$74.35M |
| Income Before Tax Ratio | $0.07 | $0.15 | -$0.10 | -$0.19 |
| Income Tax Expense | -$687.65M | -$3.39M | -$52.57M | -$12.75M |
| Net Income | $835.54M | $91.41M | -$30.37M | -$61.60M |
| Net Income Ratio | $0.64 | $0.16 | -$0.04 | -$0.15 |
| EPS | $11.78 | $1.52 | -$0.51 | -$1.04 |
| Diluted EPS | $11.78 | $1.39 | -$0.51 | -$1.04 |
| Weighted Avg Shares Outstanding | $70.95M | $60.09M | $59.40M | $59.31M |
| Weighted Avg Shares Outstanding (Diluted) | $70.96M | $65.76M | $59.40M | $59.31M |
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan